Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: Rationale, opportunities and challenges

• George D. Kalliolias,
• Athanasios G. Papavassiliou

Affiliations

George D. Kalliolias

Hospital for Special Surgery, Arthritis & Tissue Degeneration, New York, NY, USA; Weill Cornell Medical College, Department of Medicine, New York, NY, USA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA

Athanasios G. Papavassiliou

Correspondence to: Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street – Bldg 16, Athens 11527, Greece.; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece